Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Muscle Atrophy - Overview
Muscle Atrophy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Muscle Atrophy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Muscle Atrophy - Companies Involved in Therapeutics Development
Avidity Biosciences LLC
Emmyon Inc
Ha Pharm Co Ltd
Helixmith Co Ltd
K-Stemcell Co Ltd
Milo Biotechnology LLC
Shionogi & Co Ltd
Teijin Pharma Ltd
Muscle Atrophy - Drug Profiles
AAV9-Follistatin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Oligonucleotides for Muscle Atrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EMMY-105 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EMMY-106 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Muscular Atrophy, Sarcopenia and Traumatic Nerve Injury - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HNP-6005 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
JP-4039 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit HSD11B1 for Muscle Atrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Parry-Romberg disease and Thromboangiitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TEISARM-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Muscle Atrophy - Dormant Projects
Muscle Atrophy - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Muscle Atrophy, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Muscle Atrophy, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Muscle Atrophy - Pipeline by Avidity Biosciences LLC, H2 2019
Muscle Atrophy - Pipeline by Emmyon Inc, H2 2019
Muscle Atrophy - Pipeline by Hana Pharm Co Ltd, H2 2019
Muscle Atrophy - Pipeline by Helixmith Co Ltd, H2 2019
Muscle Atrophy - Pipeline by K-Stemcell Co Ltd, H2 2019
Muscle Atrophy - Pipeline by Milo Biotechnology LLC, H2 2019
Muscle Atrophy - Pipeline by Shionogi & Co Ltd, H2 2019
Muscle Atrophy - Pipeline by Teijin Pharma Ltd, H2 2019
Muscle Atrophy - Dormant Projects, H2 2019
Muscle Atrophy - Discontinued Products, H2 2019